DermaFrac
Commercial- Indications
- Skin rejuvenation
Company intelligence / Profile preview
Genesis Biosystems develops and markets FDA-cleared aesthetic medical devices for non-invasive skin rejuvenation. Their flagship products include the DermaFrac C microneedling + infusion system and Dermacel professional peel system. These devices are used by practitioners worldwide for anti-aging, resurfacing, lightening, and general cosmetic dermatology procedures. The company does not develop drugs or biologics but focuses on device-based solutions with strong practitioner adoption in the aesthetics market. No clinical trial data typical of pharmaceutical development applies.
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genesis Biosystems.